Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin

NCT00039962 is registered in ClinicalTrials.gov with SciClone Pharmaceuticals as lead sponsor.

NCT NCT00039962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00039962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
Lead sponsor
SciClone Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2002
Completion date
Not reported
Enrollment
500
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, hepatitis c, chronic